Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_assertion description "[After MCAM silencing in the MCAM high-expression ovarian cancer cell line SKOV-3, the cell apoptosis was increased, whereas the cell spreading and invasion were significantly reduced, which may be related with dysregulation of small RhoGTPase (RhoA and Cdc42).These results suggest that MCAM expression in ovarian cancer is highly correlated with the metastatic potential of the cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_assertion evidence source_evidence_literature NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_assertion SIO_000772 22610942 NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_assertion wasDerivedFrom befree-20150227 NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_assertion wasGeneratedBy ECO_0000203 NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP548641.RAv1F_EZvGPnRd-T7AcLzpFkBZJKEF5YB6czyPjT-QFrc130_provenance.